New York State Common Retirement Fund
GALT icon

New York State Common Retirement Fund’s Galectin Therapeutics GALT Stock Holding History

New York State Common Retirement Fund’s Portfolio GALT Stock Details GALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$63.1K Buy
+13,600
New +$35.3K ﹤0.01% 2903
2025
Q2 		– Sell
-12,600
Closed -$15.4K – 3245
2025
Q1 		$15.4K Hold
12,600
– – ﹤0.01% 3019
2024
Q4 		$16.3K Hold
12,600
– – ﹤0.01% 3073
2024
Q3 		$34.6K Sell
12,600
-32,900
-72% -$80.8K ﹤0.01% 2959
2024
Q2 		$103K Buy
+45,500
New +$138K ﹤0.01% 2783
2021
Q3 		– Sell
-259
Closed -$1K – 3415
2021
Q2 		$1K Sell
259
-24,041
-99% -$85.6K ﹤0.01% 3409
2021
Q1 		$53K Hold
24,300
– – ﹤0.01% 3206
2020
Q4 		$54K Hold
24,300
– – ﹤0.01% 3177
2020
Q3 		$65K Hold
24,300
– – ﹤0.01% 3087
2020
Q2 		$74K Hold
24,300
– – ﹤0.01% 3093
2020
Q1 		$48K Hold
24,300
– – ﹤0.01% 2990
2019
Q4 		$69K Hold
24,300
– – ﹤0.01% 3081
2019
Q3 		$89K Sell
24,300
-8,900
-27% -$32.2K ﹤0.01% 3062
2019
Q2 		$138K Buy
+33,200
New +$144K ﹤0.01% 2990
2016
Q1 		– Sell
-10,200
Closed -$17K – 3148
2015
Q4 		$17K Hold
10,200
– – ﹤0.01% 3156
2015
Q3 		$24K Sell
10,200
-10,740
-51% -$25.3K ﹤0.01% 3146
2015
Q2 		$57K Buy
20,940
+10,740
+105% +$32.4K ﹤0.01% 3189
2015
Q1 		$34K Buy
+10,200
New +$36.4K ﹤0.01% 2254

Other funds holding GALT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
WANY
Wealthspire Advisors (New York) New York $18.2B AUM 21.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

New York State Common Retirement Fund's GALT Position: Q2 2026 in Review

New York State Common Retirement Fund opened a new position in Galectin Therapeutics (GALT) in Q2 2026: 13,600 shares worth $63.1K. The stake represents ﹤0.01% of the portfolio and ranks #2903 among its holdings. This is a return to the name: New York State Common Retirement Fund previously reported a position in GALT as recently as Q1 2025.

New York State Common Retirement Fund first reported a position in GALT in Q1 2015 and has held it in 18 quarters since. The position peaked at $138K in Q2 2019. 98 funds tracked by Wall St. Rank hold GALT as of Q2 2026.

  • New York State Common Retirement Fund held 13,600 shares of Galectin Therapeutics worth $63.1K as of Q2 2026.
  • Galectin Therapeutics was a new New York State Common Retirement Fund position in Q2 2026.
  • Galectin Therapeutics made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #2903 holding.
  • New York State Common Retirement Fund first reported a position in Galectin Therapeutics in Q1 2015 and has held it in 18 quarters since.
  • New York State Common Retirement Fund's Galectin Therapeutics position peaked at $138K in Q2 2019.
  • 98 funds tracked by Wall St. Rank held Galectin Therapeutics as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.